[Corrigendum] MicroRNA‑497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl‑2

: Subsequently to the publication of the article, the authors have realized that the second and third author affiliations were presented the wrong way around, and should have been reversed. Therefore, the author affiliations in this paper should have appeared as follows: Faqing Tian1, Yong Zhan2, Wei Zhu3, Juheng Li1, Meiqin Tang1, Xiaohui Chen1 and Jian Jiang1. Departments of 1Hematology and 2Radiology, Longgang District People's Hospital of Shenzhen, Shenzhen, Guangdong 518172; 3Department of Pathology, School of Basic Medicine, Guangdong Medical University, Dongguan, Guangdong 523808, P.R. China. The authors regret that these errors and omissions were not corrected prior to the publication of the paper, and apologize to the readership for the inconvenience caused. [the original article was published in International Journal of Molecular Medicine 43: 1058‑1066, 2019; DOI: 10.3892/ijmm.2018.4019].